Clostridium Difficile Vaccine Efficacy Trial
- Conditions
- Clostridium Difficile Infection
- Interventions
- Biological: Clostridium difficile vaccineBiological: Placebo
- Registration Number
- NCT03090191
- Lead Sponsor
- Pfizer
- Brief Summary
The Clover trial is evaluating an investigational vaccine that may help to prevent Clostridium difficile infection. Participants in the study are adults 50 years of age and older, who are at risk of developing Clostridium difficile infection. The study will assess whether the vaccine prevents the disease, and whether it is safe and well tolerated.
Each subject will receive 3 doses of Clostridium difficile vaccine or placebo and be followed for up to 3 years after vaccination for potential Clostridium difficile infection.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 17535
- Evidence of a personally signed and dated informed consent document.
- Willing and able to comply with study procedures.
- Subjects with an increased risk of future contact with healthcare systems or subjects who have received systemic antibiotics in the previous 12 weeks.
- Ability to be contacted by telephone during study participation.
- Negative urine pregnancy test for female subjects of childbearing potential.
-
Investigator site staff members directly involved in the conduct of the study and their family members, site staff members otherwise supervised by the investigator, or subjects who are Pfizer employees, including their family members, directly involved in the conduct of the study.
-
Participation in other studies involving investigational drug(s)/vaccine(s) within 28 days prior to study entry until 1 month after the third vaccination.
-
Previous administration of an investigational C difficile vaccine or C difficile mAb therapy.
-
Prior episode of CDI..
-
Receipt of blood products or immunoglobulins within 6 months before enrollment.
-
Subjects who may be unable to respond to vaccination due to:
- Metastatic malignancy; or
- End-stage renal disease; or
- Any serious medical disorder likely to be fatal within the next 12 months; or
- Congenital or acquired immunodeficiency; or
- Receipt of high dose systemic corticosteroids for 14 days within 28 days of enrollment; or
- Receipt of chronic systemic treatment with other known immunosuppressant medications, or radiotherapy, within 6 months of enrollment.
-
Known infection with human immunodeficiency virus (HIV).
-
Any bleeding disorder or anticoagulant therapy that would contraindicate intramuscular injection.
-
Any contraindication to vaccination or vaccine components, including previous anaphylactic reaction to any vaccine or vaccine-related components.
-
Prior small- or large-bowel resection.
-
Any condition or treatment resulting in frequent diarrhea.
-
Other acute or chronic condition or abnormality that may increase the risk associated with study participation or IP administration or may interfere with interpretation of study results
-
Pregnant or breastfeeding female subjects; male subjects and female subjects who are sexually active and at risk for pregnancy and will not/cannot use 2 methods of contraception
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Clostridium difficile vaccine Clostridium difficile vaccine - Placebo Placebo -
- Primary Outcome Measures
Name Time Method Number of First Primary Episodes of Clostridium Difficile Infection (CDI) (Definition 1) Follow-up After Dose 3 From 14 days after Dose 3 to the end of the surveillance period (mean follow-up after dose 3 was 34.2 months) CDI definition 1 for a primary episode of CDI (no previous CDI onset in the prior 8 weeks) was defined as either a) presence of diarrhea, defined as passage of 3 or more unformed stools (Bristol stool chart types 5-7) in 24 or fewer consecutive hours, and stool sample that was positive for the toxin B gene (by polymerase chain reaction \[PCR)\] and positive for toxin A and/or toxin B, as measured in the central laboratory; or b) Pseudomembranous colitis diagnosed at colonoscopy, at surgery, or histopathologically; and corresponding stool sample that was positive for the toxin B gene (via PCR) as measured in the central laboratory. End of surveillance period was defined as accumulation of at least 40 CDI cases.
Number of First Primary Episodes of Clostridium Difficile Infection (CDI) (Definition 1) Follow-up After Dose 2 From 14 days after Dose 2 to the end of the surveillance period (mean follow-up after dose 2 was 36 months) CDI definition 1 for a primary episode of CDI (no previous CDI onset in the prior 8 weeks) was defined as either a) presence of diarrhea, defined as passage of 3 or more unformed stools (Bristol stool chart types 5-7) in 24 or fewer consecutive hours, and stool sample that was positive for the toxin B gene (by PCR) and positive for toxin A and/or toxin B, as measured in the central laboratory; or b) Pseudomembranous colitis diagnosed at colonoscopy, at surgery, or histopathologically; and corresponding stool sample that was positive for the toxin B gene (via PCR) as measured in the central laboratory. End of surveillance period was defined as accumulation of at least 40 CDI cases.
Percentage of Participants Reporting Local Reactions Within 7 Days After Dose 1 Within 7 days after Dose 1 at Month 0 Local reactions included redness, swelling and pain at injection site. These were recorded by participants in an electronic diary (e-diary). Redness and swelling were measured and recorded in measuring device units. One measuring device unit= 0.5 centimeter (cm) and graded as mild: 2.5 to 5.0 cm, moderate: greater than (\>) 5.0 to 10.0 cm, severe: \>10.0 cm. Grade 4 indicated necrosis or exfoliative dermatitis for redness and necrosis for swelling Pain at injection site was graded as mild: did not interfere with daily activity, moderate: interfered with daily activity, severe: prevented daily activity. Grade 4 indicated emergency room visit or hospitalization.
Percentage of Participants Reporting Local Reactions Within 7 Days After Dose 2 Within 7 days after Dose 2 at Month 1 Local reactions included redness, swelling and pain at injection site. These were recorded by participants in an e-diary. Redness and swelling were measured and recorded in measuring device units. One measuring device unit= 0.5 cm and graded as mild: 2.5 to 5.0 cm, moderate: \> 5.0 to 10.0 cm, severe: \>10.0 cm. Grade 4 indicated necrosis or exfoliative dermatitis for redness and necrosis for swelling. Pain at injection site was graded as mild: did not interfere with daily activity, moderate: interfered with daily activity, severe: prevented daily activity. Grade 4 indicated emergency room visit or hospitalization.
Percentage of Participants Reporting Local Reactions Within 7 Days After Dose 3 Within 7 days after Dose 3 at Month 6 Local reactions included redness, swelling and pain at injection site. These were recorded by participants in an e-diary. Redness and swelling were measured and recorded in measuring device units. One measuring device unit= 0.5 cm and graded as mild: 2.5 to 5.0 cm, moderate: \> 5.0 to 10.0 cm, severe: \>10.0 cm. Grade 4 indicated necrosis or exfoliative dermatitis for redness and necrosis for swelling. Pain at injection site was graded as mild: did not interfere with daily activity, moderate: interfered with daily activity, severe: prevented daily activity. Grade 4 indicated emergency room visit or hospitalization.
Percentage of Participants Reporting Systemic Events Within 7 Days After Dose 1 Within 7 days after Dose 1 at Month 0 Systemic events included fever, fatigue, headache, joint pain, muscle pain and vomiting. These were recorded by participants in an e-diary. Fever was categorized as: mild: (38.0 to 38.4 degree Celsius \[deg C\]), moderate: (38.5 to 38.9 deg C), severe (39.0 to 40.0 deg C), potentially life threatening (\> 40.0 deg C). Fatigue, headache, joint pain and muscle pain were graded as mild: did not interfere with activity, moderate: some interference with activity, severe: prevented daily activity, grade 4: emergency room visit or hospitalization. Vomiting was graded as mild: 1 to 2 times in 24 hours, moderate: \>2 times in 24 hours, severe: required intravenous hydration, grade 4: emergency room visit or hospitalization for hypotensive shock.
Percentage of Participants Reporting Systemic Events Within 7 Days After Dose 2 Within 7 days after Dose 2 at Month 1 Systemic events included fever, fatigue, headache, joint pain, muscle pain and vomiting. These were recorded by participants in an e-diary. Fever was categorized as: mild: (38.0 to 38.4 deg C), moderate: (38.5 to 38.9 deg C), severe (39.0 to 40.0 deg C), potentially life threatening (\> 40.0 deg C). Fatigue, headache, joint pain and muscle pain were graded as mild: did not interfere with activity, moderate: some interference with activity, severe: prevented daily activity, grade 4: emergency room visit or hospitalization. Vomiting was graded as mild: 1 to 2 times in 24 hours, moderate: \>2 times in 24 hours, severe: required intravenous hydration, grade 4: emergency room visit or hospitalization for hypotensive shock.
Percentage of Participants Reporting Systemic Events Within 7 Days After Dose 3 Within 7 days after Dose 3 at Month 6 Systemic events included fever, fatigue, headache, joint pain, muscle pain and vomiting. These were recorded by participants in an e-diary. Fever was categorized as: mild: (38.0 to 38.4 deg C), moderate: (38.5 to 38.9 deg C), severe (39.0 to 40.0 deg C), potentially life threatening (\> 40.0 deg C). Fatigue, headache, joint pain and muscle pain were graded as mild: did not interfere with activity, moderate: some interference with activity, severe: prevented daily activity, grade 4: emergency room visit or hospitalization. Vomiting was graded as mild: 1 to 2 times in 24 hours, moderate: \>2 times in 24 hours, severe: required intravenous hydration, grade 4: emergency room visit or hospitalization for hypotensive shock.
Number of Participants Reporting Adverse Events (AEs) From Day 1 of Dose 1 to 1 Month after Dose 3 (7 Months) An AE was defined as any untoward medical occurrence in a participant who received investigational product without regard to possibility of causal relationship. AEs included both serious and all non-serious adverse events. An SAE was defined as any untoward medical occurrence at any dose that resulted in any of the following outcomes: death; life-threatening (immediate risk of death); required inpatient hospitalization or prolongation of existing hospitalization; persistent or significant disability/incapacity (substantial disruption of the ability to conduct normal life functions); congenital anomaly/birth defect; or that was considered as an important medical event. AEs included both SAEs and all Non-SAEs (except local and systemic events).
Number of Participants Reporting Serious Adverse Events (SAEs) From Day 1 of Dose 1 up to 6 months after Dose 3 (up to Month 12) An SAE was defined as any untoward medical occurrence at any dose that resulted in any of the following outcomes: death; life-threatening (immediate risk of death); required inpatient hospitalization or prolongation of existing hospitalization; persistent or significant disability/incapacity (substantial disruption of the ability to conduct normal life functions); congenital anomaly/birth defect; or that was considered as an important medical event.
- Secondary Outcome Measures
Name Time Method Number of All Episodes of CDI (Definition 1 and 2) After Dose 3 From 14 days after Dose 3 to the end of the surveillance period (mean follow-up after dose 3 was 34.2 months) CDI definition 1 for primary episode of CDI (no previous CDI onset in prior 8 weeks) and CDI definition 2 for recurrent episode (episode occurred 8 weeks or less after onset of previous episode \[provided symptoms of previous episode resolved\]) were both defined as either a) presence of diarrhea, (passage of 3 or more unformed stools \[Bristol stool chart types 5-7\]) in 24 or fewer consecutive hours, stool sample positive for toxin B gene (by PCR),positive for toxin A and/or toxin B, as measured in central laboratory; or b) Pseudomembranous colitis diagnosed at colonoscopy, surgery, histopathologically; and corresponding stool sample positive for toxin B gene (via PCR) as measured in central laboratory. End of surveillance period was defined as accumulation of at least 40 CDI cases.
Time to Resolution for Participants With First Primary Episodes of CDI (Definition 1) After Dose 3 From 14 days after Dose 3 to the end of the surveillance period (mean follow-up after dose 3 was 34.2 months) Resolution of the event was the last day on which the event was recorded in the e-diary or the date the event ends if it was unresolved during the participant diary-recording period (end date collected on the case report form \[CRF\]). CDI definition 1 for a primary episode of CDI (no previous CDI onset in the prior 8 weeks) was defined as either a) presence of diarrhea, defined as passage of 3 or more unformed stools (Bristol stool chart types 5-7) in 24 or fewer consecutive hours, and stool sample that was positive for the toxin B gene (by PCR) and positive for toxin A and/or toxin B, as measured in the central laboratory; or b) Pseudomembranous colitis diagnosed at colonoscopy, at surgery, or histopathologically; and corresponding stool sample that was positive for the toxin B gene (via PCR) as measured in the central laboratory. End of surveillance period was defined as accumulation of at least 40 CDI cases.
Proportion of Participants Who Required Medical Attention During First Primary Episode of CDI (Definition 1) After Dose 3 From 14 days after Dose 3 to the end of the surveillance period (mean follow-up after dose 3 was 34.2 months) CDI definition 1 for a primary episode of CDI (no previous CDI onset in the prior 8 weeks) was defined as either a) presence of diarrhea, defined as passage of 3 or more unformed stools (Bristol stool chart types 5-7) in 24 or fewer consecutive hours, and stool sample that was positive for the toxin B gene (by PCR) and positive for toxin A and/or toxin B, as measured in the central laboratory; or b) Pseudomembranous colitis diagnosed at colonoscopy, at surgery, or histopathologically; and corresponding stool sample that was positive for the toxin B gene (via PCR) as measured in the central laboratory. End of surveillance period was defined as accumulation of at least 40 CDI cases.
Number of Participants With Recurrent Episodes of CDI (Definition 2) After Dose 3 From 14 days after Dose 3 to the end of the surveillance period (mean follow-up after dose 3 was 34.2 months) CDI definition 2 for a recurrent episode (an episode of CDI that occurred 8 weeks or less after the onset of a previous CDI episode \[provided the symptoms of the previous episode had resolved\]), was defined as either a) presence of diarrhea, defined as passage of 3 or more unformed stools (Bristol stool chart types 5-7) in 24 or fewer consecutive hours; and stool sample that was positive for the toxin B gene (by PCR) and positive for toxin A and/or toxin B, as measured in the central laboratory; or b) Pseudomembranous colitis diagnosed at colonoscopy, at surgery, or histopathologically; and corresponding stool sample that was positive for the toxin B gene (by PCR) as measured in the central laboratory. End of surveillance period was defined as accumulation of at least 40 CDI cases.
Number of All Episodes of CDI (Definition 1 and 2) After Dose 2 From 14 days after Dose 2 to the end of the surveillance period (mean follow-up after dose 2 was 36 months) CDI definition 1 for primary episode of CDI (no previous CDI onset in prior 8 weeks) and CDI definition 2 for recurrent episode (episode occurred 8 weeks or less after onset of previous episode \[provided symptoms of previous episode resolved\]) were both defined as either a) presence of diarrhea, (passage of 3 or more unformed stools \[Bristol stool chart types 5-7\]) in 24 or fewer consecutive hours, stool sample positive for toxin B gene (by PCR),positive for toxin A and/or toxin B, as measured in central laboratory; or b) Pseudomembranous colitis diagnosed at colonoscopy, surgery, histopathologically; and corresponding stool sample positive for toxin B gene (via PCR) as measured in central laboratory. End of surveillance period was defined as accumulation of at least 40 CDI cases.
Number of Participants With Recurrent Episodes of CDI (Definition 2) After Dose 2 From 14 days after Dose 2 to the end of the surveillance period (mean follow-up after dose 2 was 36 months) CDI definition 2 for a recurrent episode (an episode of CDI that occurred 8 weeks or less after the onset of a previous CDI episode \[provided the symptoms of the previous episode had resolved\]), was defined as either a) presence of diarrhea, defined as passage of 3 or more unformed stools (Bristol stool chart types 5-7) in 24 or fewer consecutive hours; and stool sample that was positive for the toxin B gene (by PCR) and positive for toxin A and/or toxin B, as measured in the central laboratory; or b) Pseudomembranous colitis diagnosed at colonoscopy, at surgery, or histopathologically; and corresponding stool sample that was positive for the toxin B gene (by PCR) as measured in the central laboratory. End of surveillance period was defined as accumulation of at least 40 CDI cases.
Number of First Primary Episode of CDI (Definition 1) After Dose 2 and Before Dose 3 From 14 days after Dose 2 to Dose 3 or the day the third vaccination was expected (168 days after Dose 2) for participants who received only 2 doses CDI definition 1 for a primary episode of CDI (no previous CDI onset in the prior 8 weeks) was defined as either a) presence of diarrhea, defined as passage of 3 or more unformed stools (Bristol stool chart types 5-7) in 24 or fewer consecutive hours, and stool sample that was positive for the toxin B gene (by PCR) and positive for toxin A and/or toxin B, as measured in the central laboratory; or b) Pseudomembranous colitis diagnosed at colonoscopy, at surgery, or histopathologically; and corresponding stool sample that was positive for the toxin B gene (via PCR) as measured in the central laboratory. End of surveillance period was defined as accumulation of at least 40 CDI cases.
Number of Participants With Recurrent Episode of CDI (Definition 2) After Dose 2 and Before Dose 3 From 14 days after Dose 2 to Dose 3 or the day the third vaccination was expected (168 days after Dose 2) for participants who received only 2 doses CDI definition 2 for a recurrent episode (an episode of CDI that occurred 8 weeks or less after the onset of a previous CDI episode \[provided the symptoms of the previous episode had resolved\]), was defined as either a) presence of diarrhea, defined as passage of 3 or more unformed stools (Bristol stool chart types 5-7) in 24 or fewer consecutive hours; and stool sample that was positive for the toxin B gene (by PCR) and positive for toxin A and/or toxin B, as measured in the central laboratory; or b) Pseudomembranous colitis diagnosed at colonoscopy, at surgery, or histopathologically; and corresponding stool sample that was positive for the toxin B gene (by PCR) as measured in the central laboratory. End of surveillance period was defined as accumulation of at least 40 CDI cases.
Trial Locations
- Locations (418)
Clinical Research Consulting, LLC
🇺🇸Milford, Connecticut, United States
Bay Pines VA Healthcare System
🇺🇸Bay Pines, Florida, United States
Multi-Specialty Research Associates, Inc.
🇺🇸Lake City, Florida, United States
Soma Medical Center
🇺🇸West Palm Beach, Florida, United States
Charisma Medical and Research Center
🇺🇸Miami Lakes, Florida, United States
Fleming Island Center for Clinical Research
🇺🇸Fleming Island, Florida, United States
Ocean Blue Medical Research Center, Inc.
🇺🇸Miami Springs, Florida, United States
Pines Care Research Center, LLC
🇺🇸Pembroke Pines, Florida, United States
Progressive Medical Research
🇺🇸Port Orange, Florida, United States
Precision Clinical Research, LLC
🇺🇸Sunrise, Florida, United States
Luminis Health Anne Arundel Medical Center
🇺🇸Annapolis, Maryland, United States
Luminis Health Research Institute: Research Office
🇺🇸Annapolis, Maryland, United States
ClinSite, LLC
🇺🇸Canton, Michigan, United States
Bozeman Health Deaconess Hospital d/b/a Bozeman Health Clinical Research
🇺🇸Bozeman, Montana, United States
Mercury Street Medical Group, PLLC
🇺🇸Butte, Montana, United States
ID Care
🇺🇸Hillsborough, New Jersey, United States
Amici Clinical Research
🇺🇸Raritan, New Jersey, United States
South Jersey Infectious Disease
🇺🇸Somers Point, New Jersey, United States
J. Lewis Research Inc. / Foothill Family Clinic Draper
🇺🇸Draper, Utah, United States
PMG Research,Inc. d/b/a PMG Research of Knoxville
🇺🇸Knoxville, Tennessee, United States
Holston Medical Group
🇺🇸Bristol, Tennessee, United States
Internal Medicine and Pediatric Associates of Bristol, PC
🇺🇸Bristol, Tennessee, United States
PMG Research of Bristol, LLC
🇺🇸Bristol, Tennessee, United States
The Ottawa Hospital Civic Campus
🇨🇦Ottawa, Ontario, Canada
Clinical Neuroscience Solutions, Inc.
🇺🇸Memphis, Tennessee, United States
Trinity Clinical Research
🇺🇸Tullahoma, Tennessee, United States
MC ''Tsaritsa Yoanna''EOOD
🇧🇬Sliven, Bulgaria
Hospital Italiano de Buenos Aires
🇦🇷C.a.b.a., Buenos Aires, Argentina
J. Lewis Research, Inc. - Jordan River Family Medicine
🇺🇸South Jordan, Utah, United States
Marshfield Medical Center - Marshfield
🇺🇸Marshfield, Wisconsin, United States
"Acibadem City Clinic University Hospital" EOOD
🇧🇬Sofia, Bulgaria
MHAT "Sveta Anna - Sofia" AD, Clinic of Internal Diseases
🇧🇬Sofia, Bulgaria
Fundacion Cardiovascular de Colombia
🇨🇴Floridablanca, Santander, Colombia
Studienzentrum Nordwest
🇩🇪Westerstede, Germany
Centro Medico Imbanaco de Cali S.A.
🇨🇴Cali, Valle DEL Cauca, Colombia
Universitaetsmedizin Rostock
🇩🇪Rostock, Germany
Praxis Dr. med. J. Springub/ W. Schwarz
🇩🇪Westerstede, Germany
Iizuka Hospital
🇯🇵Iizuka, Fukuoka, Japan
Semmelweis Egyetem III. Sz. Belgyogyaszati Klinika
🇭🇺Budapest, Hungary
Orszagos Koranyi Pulmonologiai Intezet, VI. Osztaly
🇭🇺Budapest, Hungary
DRC Kft.
🇭🇺Balatonfured, Hungary
Del-pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet, I. Belgyogyaszati Osztaly
🇭🇺Budapest, Hungary
CRU Hungary Kft.
🇭🇺Encs, Hungary
Aichi Medical University Hospital
🇯🇵Nagakute, Aichi, Japan
Miyanomori Memorial Hospital
🇯🇵Sapporo-shi, Hokkaido, Japan
Nerima General Hospital
🇯🇵Nerima-ku, Tokyo, Japan
Seishinkai Inoue Hospital
🇯🇵Itoshima, Fukuoka, Japan
Fukuoka Tokushukai Hospital
🇯🇵Kasuga, Fukuoka, Japan
Kenwakai Otemachi Hospital
🇯🇵Kitakyushu, Fukuoka, Japan
Fukuyama City Hospital
🇯🇵Fukuyama, Hiroshima, Japan
Social Medical Care Corporation Hose-kai Marunouchi Hospital
🇯🇵Matsumoto-City, Nagano Prefecture, Japan
Omi Medical Center
🇯🇵Kusatsu, Shiga, Japan
Juntendo University Hospital
🇯🇵Bunkyo-ku, Tokyo, Japan
Fukuwa Clinic
🇯🇵Chuo-ku, Tokyo, Japan
The Catholic University of Korea, St. Vincent's Hospital
🇰🇷Gyeonggi-do, Korea, Republic of
Korea University Ansan Hospital
🇰🇷Ansan, Gyeonggi-do, Korea, Republic of
Sekino Hospital
🇯🇵Toshima-ku, Tokyo, Japan
Fukui-Ken Saiseikai Hospital
🇯🇵Fukui, Japan
Japanese Red Cross Kumamoto Hospital
🇯🇵Kumamoto, Japan
Gachon University Gil Medical Center
🇰🇷Incheon, Korea, Republic of
Kyungpook National University Hospital
🇰🇷Daegu, Korea, Republic of
Inha University Hospital
🇰🇷Incheon, Korea, Republic of
Korea University Guro Hospital
🇰🇷Seoul, Korea, Republic of
Hospital Cayetano Heredia
🇵🇪San Martin de Porres, Lima, Peru
Hospital Nacional Adolfo Guevara Velasco
🇵🇪Cusco, Peru
NZOZ Vitamed
🇵🇱Bydgoszcz, Poland
Centro Hospitalar Vila Nova de Gaia/Espinho, E.P.E.
🇵🇹Vila Nova de Gaia, Portugal
PULMO-MEDIK s.r.o., Pneumologicko-ftizeologicka ambulancia
🇸🇰Bojnice, Slovakia
Medak s.r.o., Gastroenterologicka ambulancia
🇸🇰Bratislava, Slovakia
MUDr. Viliam Cibik, PhD, s.r.o.
🇸🇰Pruske, Slovakia
Synexus Polska Sp. z o.o. Oddzial w Gdyni
🇵🇱Gdynia, Poland
SYNEXUS Polska Sp. z o.o. Oddzial w Katowicach
🇵🇱Katowice, Poland
Synexus Polska Sp. z o.o. Oddział w Poznaniu
🇵🇱Poznan, Poland
Synexus Polska Sp. z o.o. Oddzial we Wroclawiu
🇵🇱Wroclaw, Poland
Hospital Senhora de Oliveira - Guimaraes, E.P.E.
🇵🇹Guimaraes, Portugal
Niepubliczny Zaklad Opieki Zdrowotnej Salmed S. C.
🇵🇱Leczna, Poland
Dionea, s.r.o.
🇸🇰Nove Zamky, Slovakia
MEDIPA, s.r.o.
🇸🇰Piestany, Slovakia
Plucna ambulancia Hrebenar s.r.o.
🇸🇰Spisska Nova Ves, Slovakia
SPAOLO s.r.o., Ambulancia vnutorneho lekarstva
🇸🇰Stara Tura, Slovakia
Privatna urologicka ambulancia, s.r.o.
🇸🇰Trencin, Slovakia
Fakutna nemocnica Trnava
🇸🇰Trnava, Slovakia
EAP Centelles
🇪🇸Centelles, Barcelona, Spain
Oak Tree Surgery
🇬🇧Liskeard, Cornwall, United Kingdom
Knowle House Surgery
🇬🇧Plymouth, Devon, United Kingdom
Layton Medical Centre
🇬🇧Blackpool, Lancashire, United Kingdom
University Hospitals of Leicester NHS Trust
🇬🇧Leicester, Leicestershire, United Kingdom
Revival Research Institute, LLC
🇺🇸Sterling Heights, Michigan, United States
UCLA CTRC Outpatient Unit
🇺🇸Los Angeles, California, United States
Snake River Research, PLLC
🇺🇸Idaho Falls, Idaho, United States
Louis Stokes Cleveland VA Medical Center
🇺🇸Cleveland, Ohio, United States
Velocity Clinical Research, Inc.
🇺🇸Cleveland, Ohio, United States
OhioHealth Riverside Methodist Hospital
🇺🇸Columbus, Ohio, United States
Remington-Davis, Incorporated
🇺🇸Columbus, Ohio, United States
St. Vincent Hospital & Health Care Center
🇺🇸Indianapolis, Indiana, United States
Finlay Medical Research
🇺🇸Miami, Florida, United States
Doctors Research Institute
🇺🇸Miami, Florida, United States
Acevedo Clinical Research Associates
🇺🇸Miami, Florida, United States
Duke University Hospital Investigational Drug Services (IDS) Pharmacy
🇺🇸Durham, North Carolina, United States
VA Loma Linda Healthcare System Research Pharmacy
🇺🇸Loma Linda, California, United States
Edward Hines Jr VA Hospital
🇺🇸Hines, Illinois, United States
Kentucky Pediatric/Adult Research
🇺🇸Bardstown, Kentucky, United States
Rochester Clinical Research
🇺🇸Rochester, New York, United States
PMG Research of Raleigh, LLC d/b/a PMG Research of Cary
🇺🇸Cary, North Carolina, United States
Washington University School of Medicine
🇺🇸Saint Louis, Missouri, United States
PMG Research of Wilmington, LLC
🇺🇸Wilmington, North Carolina, United States
Aultman Cardiology Clinical Trials
🇺🇸Canton, Ohio, United States
University of Cincinnati Medical Center
🇺🇸Cincinnati, Ohio, United States
University Of Cincinnati-Internal Medicine Division of Digestive Diseases
🇺🇸Cincinnati, Ohio, United States
University Hospitals Cleveland Medical Center
🇺🇸Cleveland, Ohio, United States
Great Lakes Medical Research LLC
🇺🇸Mentor, Ohio, United States
Riverside Methodist Hospital
🇺🇸Columbus, Ohio, United States
VA Pittsburgh Healthcare System
🇺🇸Pittsburgh, Pennsylvania, United States
Synexus US, LP
🇺🇸Dallas, Texas, United States
Wenatchee Valley Hospital & Clinics
🇺🇸Wenatchee, Washington, United States
Virginia Research Center LLC
🇺🇸Midlothian, Virginia, United States
J Lewis Research, Incorporated
🇺🇸Salt Lake City, Utah, United States
Alliance for Multispecialty Research, LLC
🇺🇸Wichita, Kansas, United States
Phoenix VA Health Care System
🇺🇸Phoenix, Arizona, United States
Phoenix Clinical LLC
🇺🇸Phoenix, Arizona, United States
Columbia Research Group, Inc.
🇺🇸Portland, Oregon, United States
VA Portland Healthcare System
🇺🇸Portland, Oregon, United States
Mayo Clinic
🇺🇸Rochester, Minnesota, United States
Barrett Clinic
🇺🇸Omaha, Nebraska, United States
North Alabama Research Center, LLC
🇺🇸Athens, Alabama, United States
Clinical Research Institute of Arizona, LLC
🇺🇸Surprise, Arizona, United States
Premier Health Research Center, LLC
🇺🇸Downey, California, United States
Usborne Family Medicine
🇺🇸Covina, California, United States
Baptist Health Center for Clinical Research
🇺🇸Little Rock, Arkansas, United States
California Kidney Specialist
🇺🇸Covina, California, United States
MedPharmics, LLC
🇺🇸Metairie, Louisiana, United States
The Pain Center of Arizona
🇺🇸Phoenix, Arizona, United States
Hope Research Institute
🇺🇸Phoenix, Arizona, United States
Kaiser Permanente Roseville
🇺🇸Roseville, California, United States
VA Long Beach Healthcare System
🇺🇸Long Beach, California, United States
Baptist Health Rehabilitation Institute
🇺🇸Little Rock, Arkansas, United States
Arkansas Gastroenterology
🇺🇸North Little Rock, Arkansas, United States
Paradigm Clinical Research Centers, Inc.
🇺🇸Redding, California, United States
VA Northern California Health Care System
🇺🇸Mather, California, United States
Kaiser Permanente Walnut Creek
🇺🇸Walnut Creek, California, United States
Optimus U. Corp.
🇺🇸Miami, Florida, United States
Breakthrough Clinical Trials
🇺🇸San Bernardino, California, United States
Southeast Clinical Research
🇺🇸Chiefland, Florida, United States
Medical Research Center of Connecticut, LLC
🇺🇸Hamden, Connecticut, United States
Next Phase Research Alliance
🇺🇸Miami, Florida, United States
Christie Clinic, LLC
🇺🇸Champaign, Illinois, United States
Omega Research Consultants, LLC
🇺🇸DeBary, Florida, United States
Innovative Research of West FL., Inc.
🇺🇸Clearwater, Florida, United States
Indago Research & Health Center, Inc
🇺🇸Hialeah, Florida, United States
Solaris Clinical Research
🇺🇸Meridian, Idaho, United States
Clinical Neuroscience Solutions,Inc.
🇺🇸Jacksonville, Florida, United States
Barnes-Jewish Hospital
🇺🇸Saint Louis, Missouri, United States
Advanced Clinical Research
🇺🇸Meridian, Idaho, United States
St. Vincent Hospital and Health Care Center
🇺🇸Indianapolis, Indiana, United States
Luminis Health Anne Arundel Medical Center Infusion Center
🇺🇸Annapolis, Maryland, United States
Mayo Clinic Rochester, Methodist Hospital Campus
🇺🇸Rochester, Minnesota, United States
Tandem Clinical Research, LLC
🇺🇸Marrero, Louisiana, United States
Barnes Jewish Hospital
🇺🇸Saint Louis, Missouri, United States
UC Health Physicians Office Clifton
🇺🇸Cincinnati, Ohio, United States
New Mexico VA Healthcare System
🇺🇸Albuquerque, New Mexico, United States
Center for Advanced Medicine
🇺🇸Saint Louis, Missouri, United States
Center For Clinical Studies
🇺🇸Saint Louis, Missouri, United States
Aa Mrc Llc
🇺🇸Flint, Michigan, United States
PMG Research of Charlotte, LLC
🇺🇸Charlotte, North Carolina, United States
Waterway Primary Care LLC DBA Tabor City Family Medicine
🇺🇸Tabor City, North Carolina, United States
Durham VAMC
🇺🇸Durham, North Carolina, United States
Sterling Research Group, Ltd.
🇺🇸Cincinnati, Ohio, United States
Meridian Clinical Research, LLC
🇺🇸Endwell, New York, United States
Bozeman Health GI Clinic
🇺🇸Bozeman, Montana, United States
Meridian Clinical Research LLC
🇺🇸Binghamton, New York, United States
Capital Area Research, LLC
🇺🇸Camp Hill, Pennsylvania, United States
Drexel University College of Medicine
🇺🇸Philadelphia, Pennsylvania, United States
Kaiser Permanente Center For Health Research
🇺🇸Portland, Oregon, United States
Liberty Family Practice
🇺🇸Erie, Pennsylvania, United States
PMG Research of Hickory, LLC
🇺🇸Hickory, North Carolina, United States
Paratus Clinical Pty Ltd
🇦🇺Kanwal, New South Wales, Australia
Main Street Physician's Care - Waterway
🇺🇸Little River, South Carolina, United States
PharmQuest
🇺🇸Greensboro, North Carolina, United States
Wake Research Associates, LLC
🇺🇸Raleigh, North Carolina, United States
Aultman Hospital
🇺🇸Canton, Ohio, United States
PriMED Clinical Research
🇺🇸Dayton, Ohio, United States
Lehigh Valley Health Network/Network Office of Research and Innovation
🇺🇸Allentown, Pennsylvania, United States
PMG Research of Raleigh, LLC
🇺🇸Raleigh, North Carolina, United States
DM Clinical Research
🇺🇸Tomball, Texas, United States
Martin Diagnostic Clinic
🇺🇸Tomball, Texas, United States
Westminster Family Medicine
🇺🇸Erie, Pennsylvania, United States
Kelsey Research Foundation
🇺🇸Houston, Texas, United States
Clinical Alliance for Research & Education - Infectious Diseases, LLC
🇺🇸Annandale, Virginia, United States
Kelsey-Seybold Clinic
🇺🇸Houston, Texas, United States
Diagnostics Research Group
🇺🇸San Antonio, Texas, United States
South Texas Veterans Healthcare System, Audie L Murphy Hospital
🇺🇸San Antonio, Texas, United States
University of Texas Medical Branch
🇺🇸Galveston, Texas, United States
Clinical Trials of Texas, Inc.
🇺🇸San Antonio, Texas, United States
University of North Texas Health Science Center at Fort Worth
🇺🇸Fort Worth, Texas, United States
Universal Research Group, LLC
🇺🇸Tacoma, Washington, United States
Salem VAMC
🇺🇸Salem, Virginia, United States
Synexus US, dba Research Across America
🇺🇸Mesquite, Texas, United States
LinQ Research, LLC
🇺🇸Pearland, Texas, United States
North Texas Infectious Diseases Consultants, P.A.
🇺🇸Dallas, Texas, United States
Texas Center for Drug Development, Inc.
🇺🇸Houston, Texas, United States
J. Lewis Research, Inc./Foothill Family Clinic
🇺🇸Salt Lake City, Utah, United States
MultiCare Institute for Research & Innovation
🇺🇸Tacoma, Washington, United States
Sanatorio Británico S.A.
🇦🇷Rosario, Santa FE, Argentina
Advanced Clinical Research/Gut Whisperer
🇺🇸Riverton, Utah, United States
Frandsen Family Medicine DBA Sound Medical Research
🇺🇸Port Orchard, Washington, United States
"MHAT- Dr. Hristo Stambolski" EOOD
🇧🇬Kazanlak, Bulgaria
UMHAT "Dr. Georgi Stranski" EAD, Second Psychiatric Clinic of general psychiatry and dependence
🇧🇬Pleven, Bulgaria
Linear Clinical Research
🇦🇺Nedlands, Western Australia, Australia
UMHAT "Sveti Georgi" EAD
🇧🇬Plovdiv, Bulgaria
''Medical Center-1-Sevlievo'' EOOD
🇧🇬Sevlievo, Bulgaria
Eastern Health - Box Hill Hospital
🇦🇺Box Hill, Victoria, Australia
MHAT "Sv. Nikolay Chudotvorets" EOOD
🇧🇬Lom, Bulgaria
Mater Misericordiae Ltd & Mater Medical Research Institute Ltd
🇦🇺South Brisbane, Queensland, Australia
Barwon Health
🇦🇺Geelong, Victoria, Australia
MC Medica Plus OOD
🇧🇬Veliko Tarnovo, Bulgaria
Emeritus Research
🇦🇺Camberwell, Victoria, Australia
CHU de Liège - Domaine universitaire du Sart Tilman
🇧🇪Liege, Belgium
Acibadem City Clinic Tokuda Ead
🇧🇬Sofia, Bulgaria
Institut Jules Bordet
🇧🇪Brussels, Belgium
UZ Leuven
🇧🇪Leuven, Belgium
MHAT ''Sv.Ivan Rilski-Kozloduy'' EOOD; Internal Department
🇧🇬Kozloduy, Bulgaria
"SHATPD-Troyan" EOOD
🇧🇬Troyan, Bulgaria
"Center for Mental Health - Ruse" EOOD
🇧🇬Ruse, Bulgaria
SHATPPD Dr. Dimitar Gramatikov - Ruse EOOD
🇧🇬Ruse, Bulgaria
MHAT -Silistra AD
🇧🇬Silistra, Bulgaria
MC 'Cardiohelp' EOOD
🇧🇬Sofia, Bulgaria
Vancouver Coastal Health Research Institution-clinical research unit-Diamond Health Care Centre
🇨🇦Vancouver, British Columbia, Canada
The Ottawa Hospital General Campus
🇨🇦Ottawa, Ontario, Canada
Instituto de Coloproctologia ICO
🇨🇴Medellin, Antioquia, Colombia
Slezska Nemocnice v Opave, prispevkova organizace
🇨🇿Opava, Czechia
Centro de Investigaciones - MedPlus Centro de Recuperación Integral S.A.S.
🇨🇴Bogota, D.c., Colombia
Policska nemocnice s.r.o.,
🇨🇿Policka, Czechia
SIBAmed Studienzentrum GmbH & Co.KG
🇩🇪Leipzig, Germany
Gemeinschaftspraxis Dr. med. Heidrun Taeschner und Dr. med. Susanne Bonigut
🇩🇪Leipzig, Germany
Ordinace vseobecneho praktickeho lekare
🇨🇿Benatky nad Jizerou, Czechia
Oblastni nemocnice Pribram, a.s.
🇨🇿Pribram I., Czechia
CIC Vaccinologie Cochin- Pasteur 1417
🇫🇷Paris, France
EUGASTRO GmbH/ Praxis
🇩🇪Leipzig, Germany
Budapesti Szent Ferenc Korhaz, Kardiologiai Rehabilitacios Osztaly
🇭🇺Budapest, Hungary
Klinikum Wuerzburg Mitte gGmbH
🇩🇪Wuerzburg, Germany
Bajai Szent Rokus Korhaz, II Belgyogyaszat
🇭🇺Baja, Hungary
ClinTrial Audit Kft., Klinikai Farmakologiai Intezet, Vedooltasi Ambulancia
🇭🇺Debrecen, Hungary
Somogy Megyei Kaposi Mor Oktato Korhaz, Infektologiai Osztaly
🇭🇺Kaposvar, Hungary
Tokai Memorial Hospital
🇯🇵Kasugai, Aichi, Japan
Daido Clinic
🇯🇵Nagoya, Aichi, Japan
Kamiiida daiichi General Hospital
🇯🇵Nagoya, Aichi, Japan
Nozaki Tokushukai Hospital
🇯🇵Daito, Osaka, Japan
Medical Corporation Tokushukai Koga General Hospital
🇯🇵Koga, Ibaraki, Japan
Saga-Ken Medical Centre Koseikan
🇯🇵Saga, Japan
Yonsei University Wonju Severance Christian Hospital
🇰🇷Wonju-si, Gangwon-do, Korea, Republic of
Hallym University Kangdong Sacred Heart Hospital
🇰🇷Seoul, Korea, Republic of
Mito Kyodo General Hospital
🇯🇵Mito, Ibaraki, Japan
Yaizu City Hospital
🇯🇵Yaizu, Shizuoka, Japan
Yokosuka Kyosai Hospital
🇯🇵Yokosuka, Kanagawa, Japan
Osaki Citizen Hospital
🇯🇵Osaki, Miyagi, Japan
Asan Medical Center
🇰🇷Songpa-gu, Seoul, Korea, Republic of
Dong-A University Hospital
🇰🇷Busan, Korea, Republic of
Korea University Anam Hospital
🇰🇷Seoul, Korea, Republic of
Samsung Medical Center
🇰🇷Seoul, Korea, Republic of
Clinica Internacional S.A
🇵🇪Lima, Peru
Synexus Polska Sp. z o.o Oddzial w Gdansku
🇵🇱Gdansk, Poland
Synexus Polska Sp. z o.o. Oddzial w Warszawie
🇵🇱Warszawa, Poland
MUDr. Zakova, s.r.o.
🇸🇰Trencin, Slovakia
Hallym University Kangnam Sacred Heart Hospital
🇰🇷Seoul, Korea, Republic of
Centro Hospitalar do Baixo Vouga, E.P.E.
🇵🇹Aveiro, Portugal
Hospital de Braga
🇵🇹Braga, Portugal
Parc de Salut Mar- Hospital del Mar
🇪🇸Barcelona, Spain
Complejo Hospitalario Universitario A Coruna
🇪🇸A Coruna, Spain
Stalerg, s.r.o.
🇸🇰Kosice, Slovakia
Medilex s.r.o., Interna ambulancia
🇸🇰Rimavska Sobota, Slovakia
Avdelningen for kliniska provningar, S-huset
🇸🇪Orebro, Sweden
Kaohsiung Veterans General Hospital
🇨🇳Kaohsiung City, Taiwan (r.o.c.), Taiwan
The Alverton Practise, St Clare Medical Centre
🇬🇧Penzance, Cornwall, United Kingdom
Infektionskliniken, Malarsjukhuset
🇸🇪Eskilstuna, Sweden
Sahlgrenska Universitetssjukhuset - Ostra Sjukhuset
🇸🇪Goteborg, Sweden
Karolinska Trial Alliance, KTA Prim Sabbatsbergs sjukhus
🇸🇪Stockholm, Sweden
National Taiwan University Hospital
🇨🇳Taipei, Taiwan
Hospital Universitario Fundacion Jimenez Diaz
🇪🇸Madrid, Spain
Fowey River Practice
🇬🇧Fowey, Cornwall, United Kingdom
Rame Group Practice, Rame Medical Ltd.
🇬🇧Torpoint, Cornwall, United Kingdom
Heart of England NHS Foundation Trust
🇬🇧Birmingham, WEST Midlands, United Kingdom
Far Eastern Memorial Hospital
🇨🇳New Taipei City, Taiwan
Gothia Forum CTC/Sahlgrenska Universitetssjukhuset
🇸🇪Göteborg, Sweden
Stockport Nhs Foundation Trust
🇬🇧Stockport, Cheshire, United Kingdom
Newcastle upon Tyne Hospitals NHS Foundation trust
🇬🇧Newcastle upon Tyne, United Kingdom
St James University Hospital
🇬🇧Leeds, United Kingdom
Royal Devon & Exeter Hospital
🇬🇧Exeter, Devon, United Kingdom
NHS Lothian, Western General Hospital
🇬🇧Edinburgh, Midlothian, United Kingdom
Hospital Clinic de Barcelona
🇪🇸Barcelona, Spain
Hospital Universitario de la Princesa
🇪🇸Madrid, Spain
Hospital de la Santa Creu i Sant Pau
🇪🇸Barcelona, Spain
Hospital Universitario Gregorio Marañón
🇪🇸Madrid, Spain
Hospital Universitario Ramon y Cajal
🇪🇸Madrid, Spain
Hospital Universitari i Politecnic La Fe
🇪🇸Valencia, Spain
Hospital Universitario Virgen Macarena
🇪🇸Sevilla, Spain
One Community Health
🇺🇸Sacramento, California, United States
Kaiser Permanente Sacramento
🇺🇸Sacramento, California, United States
CTSC Clinical Research Center
🇺🇸Sacramento, California, United States
Lawrence J. Ellison Ambulatory Care Center
🇺🇸Sacramento, California, United States
University of California, Davis Medical Center
🇺🇸Sacramento, California, United States
Kaiser Permanente South Sacramento
🇺🇸Sacramento, California, United States
Clinical Neuroscience Solutions, Inc. dba CNS Healthcare
🇺🇸Orlando, Florida, United States
Clinical Trial Center University of Colorado Denver, School of Medicine
🇺🇸Aurora, Colorado, United States
HMD Research LLC
🇺🇸Orlando, Florida, United States
University of Colorado Clinical & Translational Research Center Clinic
🇺🇸Aurora, Colorado, United States
University of Colorado Denver, School of Medicine
🇺🇸Aurora, Colorado, United States
University of Colorado Clinical & Translational Research Center Outpatient Clinic
🇺🇸Aurora, Colorado, United States
University of Colorado Department of AIP 2. Pharmacy Bulk Storage
🇺🇸Aurora, Colorado, United States
VA Ann Arbor Healthcare System
🇺🇸Ann Arbor, Michigan, United States
PMG Research of Winston-Salem, LLC
🇺🇸Winston-Salem, North Carolina, United States
Progressive Medicine of the Triad, LLC
🇺🇸Winston-Salem, North Carolina, United States
VA Loma Linda Healthcare System
🇺🇸Loma Linda, California, United States
Coastal Clinical Research, LLC, An AMR Company
🇺🇸Mobile, Alabama, United States
Long Beach Clinical Trials Services, Inc.
🇺🇸Long Beach, California, United States
Academic Medical Research Institute
🇺🇸Los Angeles, California, United States
Ronald Reagan UCLA Medical Center
🇺🇸Los Angeles, California, United States
Long Beach Clinical Trials
🇺🇸Long Beach, California, United States
Covigilant Research, LLC
🇺🇸Rancho Mirage, California, United States
Covigilant Research LLC
🇺🇸Riverside, California, United States
Veterans Affairs Palo Alto Health Care System
🇺🇸Palo Alto, California, United States
Kaiser Permanente San Jose
🇺🇸San Jose, California, United States
VA San Diego Healthcare System
🇺🇸San Diego, California, United States
VA Loma Linda Healthcare System Ambulatory Care System
🇺🇸Redlands, California, United States
Alta California Medical Group
🇺🇸Simi Valley, California, United States
Kaiser Permanente Santa Clara
🇺🇸Santa Clara, California, United States
California Kidney Specialists
🇺🇸San Dimas, California, United States
Gastroenterology Center of Connecticut, PC
🇺🇸Hamden, Connecticut, United States
Florida Sleep Disorder Center of Brandon
🇺🇸Brandon, Florida, United States
Accel Research Sites - DeLand Clinical Research Unit
🇺🇸DeLand, Florida, United States
Teradan Clinical Trials
🇺🇸Brandon, Florida, United States
Alliance for Multispecialty Reseach, LLC
🇺🇸Coral Gables, Florida, United States
Springfield Clinic Infectious Diseases
🇺🇸Springfield, Illinois, United States
Clinical Research Atlanta
🇺🇸Stockbridge, Georgia, United States
Atlanta VA Medical Center
🇺🇸Decatur, Georgia, United States
Meridian Clinical Research
🇺🇸Sioux City, Iowa, United States
Infectious Disease of Indiana, PSC
🇺🇸Carmel, Indiana, United States
Community Clinical Research Center
🇺🇸Anderson, Indiana, United States
St. Vincent Outpatient Treatment Center
🇺🇸Carmel, Indiana, United States
Deaconess Clinic Mt. Pleasant
🇺🇸Evansville, Indiana, United States
MOC Research
🇺🇸Mishawaka, Indiana, United States
Barnum Medical Research Inc
🇺🇸Natchitoches, Louisiana, United States
MedPharmics
🇺🇸Gulfport, Mississippi, United States
Center for Outpatient Health
🇺🇸Saint Louis, Missouri, United States
Duke Early Phase Clinical Research
🇺🇸Durham, North Carolina, United States
PMG Research of Salisbury, LLC
🇺🇸Salisbury, North Carolina, United States
Lillestol Research LLC
🇺🇸Fargo, North Dakota, United States
PMG Research of Rocky Mount, LLC
🇺🇸Rocky Mount, North Carolina, United States
IPS Research Company
🇺🇸Oklahoma City, Oklahoma, United States
Velocity Clinical Research, Providence
🇺🇸East Greenwich, Rhode Island, United States
PMG Research, Inc. d/b/a PMG Research of Knoxville
🇺🇸Knoxville, Tennessee, United States
Texas Health Care, PLLC
🇺🇸Fort Worth, Texas, United States
Coastal Carolina Research Center
🇺🇸North Charleston, South Carolina, United States
Ventavia Research Group, LLC
🇺🇸Fort Worth, Texas, United States
Preferred Primary Care Physicians, Inc.
🇺🇸Uniontown, Pennsylvania, United States
Hospital Nuestra Senora de la Misericordia
🇦🇷Cordoba, Argentina
Australian Clinical Research Network
🇦🇺Maroubra, Australia
Hospital Aleman
🇦🇷C.a.b.a., Buenos Aires, Argentina
Centro Médico Dra. De Salvo
🇦🇷C.a.b.a., Buenos Aires, Argentina
Austrials Pty Ltd
🇦🇺Sherwood, Queensland, Australia
Maroubra Medical Centre
🇦🇺Maroubra, New South Wales, Australia
University Clinic Pharmacy
🇦🇺Westmead, New South Wales, Australia
Westmead Hospital
🇦🇺Westmead, New South Wales, Australia
MHAT ''Sveta Petka" AD
🇧🇬Vidin, Bulgaria
Q & T Research Outaouais Inc.
🇨🇦Gatineau, Quebec, Canada
Intermed Groupe Santé
🇨🇦Chicoutimi, Quebec, Canada
Centre Integre de Sante et de Services Sociaux de la Monteregie- Center- Hopital Charles LeMoyne
🇨🇦Greenfield Park, Quebec, Canada
Manna Research Inc. (Toronto)
🇨🇦Toronto, Ontario, Canada
CIUSSS de l'Estrie - CHUS
🇨🇦Sherbrooke, Quebec, Canada
Centre Integre Universitaire de Santé et de Services Sociaux de la Mauricie et du Centre du Québec
🇨🇦Trois-Rivieres, Quebec, Canada
Centre de recherche du CHU de Quebec-Universite Laval
🇨🇦Quebec, Canada
Centre de recherche Saint-Louis
🇨🇦Quebec, Canada
ALPHA Recherche Clinique
🇨🇦Quebec, Canada
Centro de Investigacion Clínica del Sur
🇨🇱Temuco, IX Region DE LA Araucania, Chile
Psicomed Esudios Medicos
🇨🇱Antofagasta, Region DE Antofagasta, Chile
Hospital Dr. Hernan Henriquez Aravena
🇨🇱Temuco, Region DE LA Araucania, Chile
Biomedica Research Group
🇨🇱Santiago, Región Metropolitana, Chile
Fundacion Arriaran
🇨🇱Santiago, Región Metropolitana, Chile
Fundacion Centro de Investigacion Clinica - CIC
🇨🇴Medellin, Antioquia, Colombia
Clinica de la Costa Ltda.
🇨🇴Barranquilla, Atlantico, Colombia
Hospital Pablo Tobon Uribe
🇨🇴Medellin, Antioquia, Colombia
Kokkola Vaccine Research Clinic
🇫🇮Kokkola, Finland
Asociación IPS Médicos Internistas de Caldas
🇨🇴Manizales, Caldas, Colombia
Fundación Cardiomet CEQUIN
🇨🇴Armenia, Quindío, Colombia
Fundacion Valle del Lili
🇨🇴Cali, Valle DEL Cauca, Colombia
Doktor Brno s.r.o.
🇨🇿Brno, Czech, Czechia
Nemocnice Kyjov, prispevkova organizace, Infekcni oddeleni
🇨🇿Kyjov, Czechia
Sarkamed s.r.o.
🇨🇿Slany, Czechia
Interna a kardiologie s.r.o.
🇨🇿Roznov pod Radhostem, Czechia
Krajska zdravotni, a.s., Masarykova nemocnice Usti nad Labem
🇨🇿Usti nad Labem, Czechia
Fakultni nemocnice v Motole
🇨🇿Praha 5, Czechia
Nemocnice Slany, p.o.
🇨🇿Slany, Czechia
Helsinki University Central Hospital
🇫🇮Helsinki, Finland
CHU DIJON BOURGOGNE- Hopital Francois Mitterrand
🇫🇷Dijon cedex, France
Pori Vaccine Research Clinic
🇫🇮Pori, Finland
Turku Vaccine Research Clinic
🇫🇮Turku, Finland
Oulu Vaccine Research Clinic
🇫🇮Oulu, Finland
Tampere Vaccine Research Clinic
🇫🇮Tampere, Finland
Hopital Nord-CHU Saint Etienne
🇫🇷Saint Priest en Jarez, France
Emovis GmbH
🇩🇪Berlin, Germany
CHRU de Tours- Hopital Bretonneau
🇫🇷Tours Cedex 09, France
MECS Cottbus GmbH
🇩🇪Cottbus, Germany
Universitaetsklinikum Essen, Klinik fuer Infektiologie
🇩🇪Essen, Germany
Diabetologische Gemeinschaftspraxis Dr. Schaper & Dr. Faulmann
🇩🇪Dresden, Germany
Hospital Garcia de Orta
🇵🇹Almada, Portugal
Centro de Investigaciones Biomédicas - CIBIOM/Clinica Peruano Americana S.A
🇵🇪Trujillo, La Libertad, Peru
KM Management spol. s.r.o., Gastroenterologicke a hepatologicke centrum Nitra
🇸🇰Nitra, Slovakia
Hospital Universitari de Bellvitge
🇪🇸Hospitalet de Llobregat, Barcelona, Spain
Malcom Randall VA Medical Center Investigational Drug Services
🇺🇸Gainesville, Florida, United States
Malcom Randall VA Medical Center
🇺🇸Gainesville, Florida, United States
Ochsner Center for Primary Care and Wellness
🇺🇸New Orleans, Louisiana, United States
Ochsner Clinic Foundation
🇺🇸New Orleans, Louisiana, United States
Medical Research South, LLC
🇺🇸Charleston, South Carolina, United States
Tekton Research, Inc.
🇺🇸Austin, Texas, United States
East-West Medical Research Institute
🇺🇸Honolulu, Hawaii, United States
Central Kentucky Research Associates, LLC
🇺🇸Lexington, Kentucky, United States
Medical Affiliated Research Center, Inc.
🇺🇸Huntsville, Alabama, United States
Kaiser Permanente Daly City
🇺🇸Daly City, California, United States
Sundance Clinical Research
🇺🇸Saint Louis, Missouri, United States